ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
ChromaDex Corp. , the global authority on nicotinamide adenine dinucleotide and healthy-aging research, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer,...